FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to methods for diagnosing the severity of irritable bowel syndrome. Technical result is achieved by recording the enzyme deficiency and with lactase insufficiency, a slight degree of severity of irritable bowel syndrome is noted, in case of carbohydrase insufficiency, the average severity of irritable bowel syndrome and when peptidase deficiency is noted, severe and extremely severe severity of irritable bowel syndrome.
EFFECT: object of the present invention is to improve the accuracy of the diagnosis of the severity of irritable bowel syndrome.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN IRRITABLE BOWEL SYNDROME ACCOMPANIED BY DIARRHOEA | 2014 |
|
RU2570767C1 |
| DIAGNOSTIC TECHNIQUE FOR ASYMPTOMATIC CELIAC DISEASE IN ADULTS | 2020 |
|
RU2747523C1 |
| METHOD OF LACTASE DEFICIENCY IN ADULTS TREATMENT | 2017 |
|
RU2684099C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
| METHOD FOR DIAGNOSING SEVERE PSEUDOMEMBRANOUS COLITIS IN PATIENTS AFTER CORONAVIRUS INFECTION | 2022 |
|
RU2786752C1 |
| METHOD FOR IBS-SIMILAR SYNDROME DIAGNOSTICS WITH ULCERATIVE COLITIS | 2016 |
|
RU2649468C2 |
| DIAGNOSTIC METHOD OF DISACCHARIDASE DEFICIENCY IN ADULT PATIENTS | 2017 |
|
RU2655205C1 |
| METHOD OF TREATING CHRONIC CONSTIPATION AND FUNCTIONAL ANOREXIA | 2013 |
|
RU2545988C1 |
| METHOD OF THE TREATMENT OF POLYNEUROPATHY ASSOCIATED WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800847C1 |
| METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
